Innerzyme Launches Highest Potency Non-GMO Natural Vitamin K2, MK-7, 300 mcg Supplement
Scottsdale, AZ, August 29, 2013 --(PR.com
)-- Innerzyme, a highly reputable and fast growing nutraceutical company specializing in natural digestive and systemic enzyme supplements has launched the highest potency, Non-GMO Vitamin K2, MK-7 supplement on the market which provides 300 mcg in a single vegetarian capsule. Innerzyme utilizes a pure, optimum quality Vitamin K2, MK-7 as menaquinone-7 from Non-GMO fermented soybeans.
The decision to formulate and launch a high potency Vitamin K2, MK-7, 300mcg supplement came after much research into health and dietary habits of Eastern cultures and collaboration with a strategic team of healthcare professionals who focus primarily on preventative care through alternative medicine.
Vitamin K has long been recognized for its role in protein biosynthesis for the blood coagulation process. However, research now indicates that Vitamin K plays a vital part in a variety of complex physiological functions within the body. More specifically, studies show high doses of Vitamin K2, MK-7, the menaquinones, may help promote cardiovascular, bone and soft tissue health.* (1,3)
The K group of vitamins includes Vitamin K1 and Vitamin K2. It is important to know that Vitamin K1 and Vitamin K2 not only come from different sources but also have different functions.
Vitamin K1 is readily available in plant-based foods and easy to consume. The best way to get an adequate amount of Vitamin K1 is through your diet. Vitamin K1 offers adequate blood clotting support, however, there are a variety of health related issues that Vitamin K1 does not sufficiently support.* (2) Studies show these growing health issues are better addressed by Vitamin K2 in the natural form of MK-7. Although many people in Eastern cultures consume fermented soybeans, the slimy and smelly taste and texture of them often make it too harsh and unpleasant to consume.
With the growing research on the many health benefits associated with Vitamin K2, MK-7, Innerzyme wanted to offer an easier and more convenient way for people to get an adequate amount of MK-7. This new addition to the Innerzyme line of natural supplements has done just that with an easy to swallow, one a day vegetarian capsule providing 300 mcg of Vitamin K2, MK-7.
Vitamin K2, MK-7 may support:
· Cardiovascular Health*
· Bone and Soft Tissue Health*
· Arterial Calcification*
· Healthy Brain Function*
In healthy individuals, research has not reported any side effects, adverse reactions or known toxicity as a result of large doses of Vitamin K2. However, individuals on anticoagulants such as warfarin should consult their healthcare professional before adding a Vitamin K2 supplement to their daily regimen.
Innerzyme is dedicated to improving the overall quality of life for people by spreading awareness about the importance of preventative health and living a healthy lifestyle through proper diet, exercise and nutritional supplementation. Innerzyme is committed to providing people with safe, natural and effective products. Innerzyme supplements are manufactured in the USA to the highest standards in a cGMP certified facility.
For more information about Innerzyme:
Phone: (480) 284-8478
**Warning: If you have a health condition, are pregnant, nursing, lactating, trying to become pregnant or taking any medications (especially anticoagulants such as warfarin), consult your healthcare practitioner before using this product.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
(1) Beulens JW, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203:489-493.
(2) Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr. 1998;128(5):785-788.
(3) Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100-5.